Trending Now
Market make plummet before the MLK day
Markets opened higher to start the day but faded a little bit to midday. Notably, the SPY never made an hourly close...
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars
Singular Genomics Systems, Inc. (OMIC), a company specializing in next-generation sequencing (NGS) and spatial multiomics technologies, saw its stock price skyrocket after...
Popular News
Incyte (NASDAQ:INCY) Releases Phase 3 Jakafi® In Combination with SOC Study...
Incyte (NASDAQ:INCY) has released initial data from the phase 3 RUXCOVID study which showed that ruxolitinib (Jakafi®) combination with standard of care...
MAKE IT MODERN
LATEST REVIEWS
Evofem Biosciences Inc (NASDAQ:EVFM) Posts A Net Loss Of $52.7 Million...
Evofem Biosciences Inc (NASDAQ:EVFM) widened its net loss to $52.7 million in Q2 2020 compared to $35.5 million in Q1 2020. The company reduced...
MAKE IT MODERN
PERFORMANCE TRAINING
Progenity Inc. (NASDAQ: PROG) To Present Two Abstracts At The 17th Congress of the...
Progenity Inc. (NASDAQ: PROG) has announced the acceptance of two presentations with patient findings on indicators of efficacy on gastrointestinal disorders treatment by the...
ISWH Moves Towards Merging Telehealth And Crypto
An exciting conspiracy and an unexpected twist of events have led us to a renaissance in one industry, creating a potential opportunity for investors....
Markets continue their upward march unabated
Markers continue their upward march unabated. Despite rising death tolls from the coronavirus, equity markets feel obliged to push to new highs....
NRx Pharmaceuticals (NASDAQ: NRXP) Announce Publication of Aviptadil Study Results In COVID-19 Related Respiratory...
NRx Pharmaceuticals (NASDAQ: NRXP) has published peer-reviewed data from the prospective, open-label, controlled aviptadil study for respiratory failure treatment in patients with Critical coronavirus...
Acasti Pharma Inc (NASDAQ:ACST) Receives The FDA’s Written Response Regarding Request For Type C...
Acasti Pharma Inc (NASDAQ:ACST) has announced that the Food and Drug Administration (FDA) responded to its request for a TRILOGY 1 Briefing Package, as...
MAKE IT MODERN
